Comscore Reports Q2 2024 Earnings Reflecting Strategic Transition
Comscore's Q2 2024 earnings show a decline in revenue but highlight a strategic shift towards growth by Q4 2024.
- Latest
- Trending
Comscore's Q2 2024 earnings show a decline in revenue but highlight a strategic shift towards growth by Q4 2024.
Supernus Pharmaceuticals sees a 24% YoY revenue increase in Q2 2024, driven by key drugs Qelbree and GOCOVRI.
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Kornit Digital Ltd reported Q2 EPS of $0.02, beating estimates by $0.03. Q3 revenue guidance set between $48M-$52M.
Expert panel forecasts Dogecoin nearing its all-time high of $0.73 by 2030, with a potential ROI of 600%.
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Hyundai will invest $28 million in Thailand to assemble electric vehicles and batteries, starting production in 2026.
Uber reports 21% gross bookings growth and 71% EBITDA rise in Q2 2024, eyes expansion in AV market.
The Federal Reserve's expected rate cuts could significantly affect Bitcoin, Solana, and Dogecoin, offering potential investment opportunities.
Predicting Bitcoin's price in 72 hours using historical data reveals potential short-term bullish trends and high volatility. Strategic tips included.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.